| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
PTH-CALCITONIN-VITAMIN D-BONE |
-Hydroxylase Gene
Department of Pathology and Tumor Biology (T.Y., T.F., Y.-I.N.), The Graduate School of Medicine, Kyoto University, Kyoto 606-8501, Japan; The Organization for Pharmaceutical Safety and Research (T.Y.), Tokyo, 100-0013 Japan; and Core Research for Evolutional Science and Technology (Y.-I.N.), Kawaguchi 332-0012, Japan
Address all correspondence and requests for reprints to: Yo-ichi Nabeshima, M.D., Ph.D., Department of Pathology and Tumor Biology, The Graduate School of Medicine, Kyoto University, Yoshida-Konoe cho, Sakyo-ku, Kyoto 606-8501, Japan. E-mail: nabemr{at}lmls.med.kyoto-u.ac.jp
Homozygous klotho mutant (kl-/-) mice exhibit multiple phenotypes resembling human aging. To elucidate the molecular basis of these singular phenotypes, we focused on the mechanisms underlying increased serum concentrations of calcium and phosphorus in kl-/- mice. Serum concentrations of calcitonin and PTH of kl-/- mice were normally up- and down-regulated, respectively, in response to the high levels of calcium. On the other hand, despite the high concentrations of calcium, serum levels of 1,25-dihydroxyvitamin D [1,25-(OH)2D] in kl-/- mice were significantly higher than that of wild type (WT). The expression of 25-hydroxyvitamin D 1
-hydroxylase gene, the key enzyme of vitamin D metabolism, was also greatly enhanced in kidneys of kl-/- mice. Furthermore, the normal genetic responses to administered 1,25-(OH)2D3, such as down-regulation of the 25-hydroxyvitamin D 1
-hydroxylase gene and up-regulation of 24-hydroxylase and VDR genes, were apparently impaired in kl-/- mice. These findings suggest that this deterioration in the vitamin D endocrine system may result in many of the phenotypes in kl-/- mice through effects of increased levels of calcium and phosphorus and 1,25-(OH)2D. Klotho protein may participate in calcium and phosphorus homeostasis via the regulation of the 1,25-(OH)2D signaling pathway.
This article has been cited by other articles:
![]() |
R. T. Alexander, T. E. Woudenberg-Vrenken, J. Buurman, H. Dijkman, B. C. J. van der Eerden, J. P.T.M. van Leeuwen, R. J. Bindels, and J. G. Hoenderop Klotho Prevents Renal Calcium Loss J. Am. Soc. Nephrol., November 1, 2009; 20(11): 2371 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Cha, M.-C. Hu, H. Kurosu, M. Kuro-o, O. Moe, and C.-L. Huang Regulation of Renal Outer Medullary Potassium Channel and Renal K+ Excretion by Klotho Mol. Pharmacol., July 1, 2009; 76(1): 38 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Kuro-o Klotho in chronic kidney disease--What's new? Nephrol. Dial. Transplant., June 1, 2009; 24(6): 1705 - 1708. [Full Text] [PDF] |
||||
![]() |
S. Ichikawa, A. H. Sorenson, A. M. Austin, D. S. Mackenzie, T. A. Fritz, A. Moh, S. L. Hui, and M. J. Econs Ablation of the Galnt3 Gene Leads to Low-Circulating Intact Fibroblast Growth Factor 23 (Fgf23) Concentrations and Hyperphosphatemia Despite Increased Fgf23 Expression Endocrinology, June 1, 2009; 150(6): 2543 - 2550. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takei, H. Yamamoto, M. Masuda, T. Sato, Y. Taketani, and E. Takeda Stanniocalcin 2 is positively and negatively controlled by 1,25(OH)2D3 and PTH in renal proximal tubular cells J. Mol. Endocrinol., March 1, 2009; 42(3): 261 - 268. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wu, B. Lemon, X. Li, J. Gupte, J. Weiszmann, J. Stevens, N. Hawkins, W. Shen, R. Lindberg, J.-L. Chen, et al. C-terminal Tail of FGF19 Determines Its Specificity toward Klotho Co-receptors J. Biol. Chem., November 28, 2008; 283(48): 33304 - 33309. [Abstract] [Full Text] [PDF] |
||||
![]() |
S.-K. Cha, B. Ortega, H. Kurosu, K. P. Rosenblatt, M. Kuro-o, and C.-L. Huang Removal of sialic acid involving Klotho causes cell-surface retention of TRPV5 channel via binding to galectin-1 PNAS, July 15, 2008; 105(28): 9805 - 9810. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Suzuki, Y. Uehara, K. Motomura-Matsuzaka, J. Oki, Y. Koyama, M. Kimura, M. Asada, A. Komi-Kuramochi, S. Oka, and T. Imamura {beta}Klotho Is Required for Fibroblast Growth Factor (FGF) 21 Signaling through FGF Receptor (FGFR) 1c and FGFR3c Mol. Endocrinol., April 1, 2008; 22(4): 1006 - 1014. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Razzaque Klotho and Na+,K+-ATPase activity: solving the calcium metabolism dilemma? Nephrol. Dial. Transplant., February 1, 2008; 23(2): 459 - 461. [Full Text] [PDF] |
||||
![]() |
X. Wu, H. Ge, J. Gupte, J. Weiszmann, G. Shimamoto, J. Stevens, N. Hawkins, B. Lemon, W. Shen, J. Xu, et al. Co-receptor Requirements for Fibroblast Growth Factor-19 Signaling J. Biol. Chem., October 5, 2007; 282(40): 29069 - 29072. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Imura, Y. Tsuji, M. Murata, R. Maeda, K. Kubota, A. Iwano, C. Obuse, K. Togashi, M. Tominaga, N. Kita, et al. {alpha}-Klotho as a Regulator of Calcium Homeostasis Science, June 15, 2007; 316(5831): 1615 - 1618. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. B. Drueke and D. Prie Klotho spins the thread of life--what does Klotho do to the receptors of fibroblast growth factor-23 (FGF23)? Nephrol. Dial. Transplant., June 1, 2007; 22(6): 1524 - 1526. [Full Text] [PDF] |
||||
![]() |
J.-P. Stasch, P.M. Schmidt, P.I. Nedvetsky, T.Y. A. Nedvetskaya, H.S. Kumar, S. Meurer, M. Deile, A. Taye, A. Knorr, H. Lapp, et al. Endothelial Cell Dysfunction--Can One Outsmart Oxidative Stress by Direct Interaction with the Pathological Oxidized or Heme-Free Soluble Guanyl-Cyclase?: Targeting the Heme-Oxydized Nitric Oxide Receptor for Selective Vasodilatation of Diseased Blood Vessels. J Clin Invest 116: 2552-2561, 2006 J. Am. Soc. Nephrol., March 1, 2007; 18(3): 663 - 669. [Full Text] [PDF] |
||||
![]() |
H. Segawa, S. Yamanaka, Y. Ohno, A. Onitsuka, K. Shiozawa, F. Aranami, J. Furutani, Y. Tomoe, M. Ito, M. Kuwahata, et al. Correlation between hyperphosphatemia and type II Na-Pi cotransporter activity in klotho mice Am J Physiol Renal Physiol, February 1, 2007; 292(2): F769 - F779. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tsuruoka, K. Nishiki, T. Ioka, H. Ando, Y. Saito, M. Kurabayashi, R. Nagai, and A. Fujimura Defect in parathyroid-hormone-induced luminal calcium absorption in connecting tubules of Klotho mice Nephrol. Dial. Transplant., October 1, 2006; 21(10): 2762 - 2767. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Lewin and K. Olgaard Klotho, an important new factor for the activity of Ca2+ channels, connecting calcium homeostasis, ageing and uraemia Nephrol. Dial. Transplant., July 1, 2006; 21(7): 1770 - 1772. [Full Text] [PDF] |
||||
![]() |
H. Kurosu, Y. Ogawa, M. Miyoshi, M. Yamamoto, A. Nandi, K. P. Rosenblatt, M. G. Baum, S. Schiavi, M.-C. Hu, O. W. Moe, et al. Regulation of Fibroblast Growth Factor-23 Signaling by Klotho J. Biol. Chem., March 10, 2006; 281(10): 6120 - 6123. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Toyama, T. Fujimori, Y. Nabeshima, Y. Itoh, Y. Tsuji, R. Y. Osamura, and Y.-I. Nabeshima Impaired Regulation of Gonadotropins Leads to the Atrophy of the Female Reproductive System in klotho-Deficient Mice Endocrinology, January 1, 2006; 147(1): 120 - 129. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. J. Strewler The Spinner Meets the Stone: Klotho and Mineral Metabolism IBMS BoneKEy, November 1, 2005; 2(11): 29 - 33. [Full Text] [PDF] |
||||
![]() |
A. S. Dusso, A. J. Brown, and E. Slatopolsky Vitamin D Am J Physiol Renal Physiol, July 1, 2005; 289(1): F8 - F28. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. E. Arking, G. Atzmon, A. Arking, N. Barzilai, and H. C. Dietz Association Between a Functional Variant of the KLOTHO Gene and High-Density Lipoprotein Cholesterol, Blood Pressure, Stroke, and Longevity Circ. Res., March 4, 2005; 96(4): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. Meyer, E. Dulde, and R. A. Meyer Jr. The genomic response of the mouse kidney to low-phosphate diet is altered in X-linked hypophosphatemia Physiol Genomics, June 17, 2004; 18(1): 4 - 11. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Tohyama, A. Imura, A. Iwano, J.-N. Freund, B. Henrissat, T. Fujimori, and Y.-i. Nabeshima Klotho Is a Novel {beta}-Glucuronidase Capable of Hydrolyzing Steroid {beta}-Glucuronides J. Biol. Chem., March 12, 2004; 279(11): 9777 - 9784. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Tsujikawa, Y. Kurotaki, T. Fujimori, K. Fukuda, and Y.-I. Nabeshima Klotho, a Gene Related to a Syndrome Resembling Human Premature Aging, Functions in a Negative Regulatory Circuit of Vitamin D Endocrine System Mol. Endocrinol., December 1, 2003; 17(12): 2393 - 2403. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-I. Miyamoto, M. Ito, H. Segawa, and M. Kuwahata Molecular targets of hyperphosphataemia in chronic renal failure Nephrol. Dial. Transplant., March 1, 2003; 18(90003): iii79 - 80. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Yamashita, S. Okada, K. Higashio, Y.-i. Nabeshima, and M. Noda Double Mutations in Klotho and Osteoprotegerin Gene Loci Rescued Osteopetrotic Phenotype Endocrinology, December 1, 2002; 143(12): 4711 - 4717. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Manya, M. Inomata, T. Fujimori, N. Dohmae, Y. Sato, K. Takio, Y.-i. Nabeshima, and T. Endo Klotho Protein Deficiency Leads to Overactivation of {micro}-Calpain J. Biol. Chem., September 13, 2002; 277(38): 35503 - 35508. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |